We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
Cap. Flow
+$423M
Cap. Flow %
5.97%
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$188M
2
LH icon
Labcorp
LH
+$183M
3
AGN
Allergan Inc
AGN
+$144M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$93.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$82.2M

Top Sells

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$104M
2
CAH icon
Cardinal Health
CAH
+$104M
3
AGN
Allergan plc
AGN
+$80.7M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$60.3M
5
ELV icon
Elevance Health
ELV
+$55.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.3%
2 Consumer Discretionary 5.38%
3 Financials 4.49%
4 Industrials 3.37%
5 Technology 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LO
101
PUT
DELISTED
LORILLARD INC COM STK
LO
$12.9M 0.18%
205,400
+203,380
+10,068% +$12.6M
LO
102
DELISTED
LORILLARD INC COM STK
LO
$12.9M 0.18%
205,260
+5,911
+3% +$366K
DBVT
103
DBV Technologies
DBVT
$813M
$12.7M 0.18%
+46,817
New +$12M
CCK icon
104
Crown Holdings
CCK
$13B
$12.7M 0.18%
248,614
+180,116
+263% +$8.68M
WX
105
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$12.7M 0.18%
375,744
-60,663
-14% -$2.14M
ITCI
106
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.4M 0.17%
701,419
+863
+0.1% +$13.5K
CBST
107
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$12.2M 0.17%
+121,456
New +$9.44M
LAMR icon
108
Lamar Advertising Co
LAMR
$16.7B
$12.1M 0.17%
225,130
-76,632
-25% -$3.96M
GPK icon
109
Graphic Packaging
GPK
$3.35B
$11.7M 0.17%
861,904
+260,212
+43% +$3.22M
TRW
110
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$11.7M 0.17%
113,897
+59,067
+108% +$6.03M
SHPG
111
PUT
DELISTED
Shire pic
SHPG
$11.3M 0.16%
53,300
+52,652
+8,125% +$11.2M
TGNA
112
DELISTED
TEGNA Inc
TGNA
$11.2M 0.16%
673,324
+655,851
+3,754% +$10.6M
EBAY icon
113
eBay
EBAY
$51.2B
$11.2M 0.16%
472,299
+179,882
+62% +$4.08M
LVNTA
114
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$11.1M 0.16%
293,743
-236,709
-45% -$8.27M
GS icon
115
CALL
Goldman Sachs
GS
$289B
$11M 0.16%
57,000
+56,430
+9,900% +$10.6M
BHI
116
PUT
DELISTED
Baker Hughes
BHI
$10.9M 0.15%
+194,000
New +$10.9M
TMO icon
117
Thermo Fisher Scientific
TMO
$214B
$10.8M 0.15%
85,854
+25,154
+41% +$3.06M
MGA icon
118
Magna International
MGA
$18.8B
$10.7M 0.15%
197,666
-57,248
-22% -$2.9M
GRA
119
DELISTED
W.R. Grace & Co.
GRA
$10.7M 0.15%
112,509
+1,849
+2% +$172K
A icon
120
Agilent Technologies
A
$39.6B
$10.7M 0.15%
261,994
-20,220
-7% -$816K
EPC icon
121
Edgewell Personal Care
EPC
$1.3B
$10.7M 0.15%
112,509
+106,128
+1,663% +$9.76M
BHC icon
122
Bausch Health
BHC
$1.75B
$10.6M 0.15%
+74,176
New +$9.98M
LJPC
123
DELISTED
La Jolla Pharmaceutical Company
LJPC
$10.6M 0.15%
575,000
– –
BOBE
124
DELISTED
Bob Evans Farms, Inc.
BOBE
$10.5M 0.15%
204,874
+2,364
+1% +$119K
SCMP
125
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$10.4M 0.15%
726,144
-1,080,056
-60% -$11.4M
3 4
5
6 7

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.

  • Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
  • Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
  • Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
  • Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
  • Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
  • Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
  • Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.